Multimodal management of diffuse neonatal hemangiomatosis.
Blei
F
F
Orlow
S J
SJ
Geronemus
R
R
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001927:Brain Diseases / Q000209:etiology; D002547:Cerebral Palsy / Q000209:etiology; D003131:Combined Modality Therapy; D006391:Hemangioma / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins